Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: Providing patients with cancer who are undergoing systemic therapy with useful information about symptom management is essential to prevent unnecessary deterioration of quality of life. Objective: The aim was to evaluate whether use of an app for symptom management was associated with any change in patient quality of life or use of health resources. Methods: Outpatients with early stage breast cancer receiving systemic therapy were recruited at the Institute of Oncology in Ljubljana, Slovenia. Patients who received systemic therapy between December 2017 and March 2018 (control group) and between April 2018 and September 2018 (intervention group) were eligible. All patients received standard care, but only those in the intervention group were asked to use mPRO Mamma, an Android-based smartphone app, in addition. The app supported daily tracking of 50 symptoms, allowed users to grade their symptom severity (as mild, moderate, or severe), and also provided in-depth descriptions and recommendations based on reported symptom level. Patient-reported outcomes in both groups were assessed through the European Organisation for Research and Treatment of Cancer (EORTC) core (C-30) and breast cancer (BR-23) questionnaires, as well as a questionnaire about health resources use. The primary outcomes were the difference in the global quality of life between groups and the difference in summary score of the EORTC C-30 questionnaire between groups after 3 time periods (the first week of treatment, the first treatment cycle, and the entire treatment). The secondary outcome was the use of health resources (doctor visits and hospitalizations) in each time period. Other scales were used for exploratory analysis. Results: The mean difference between the intervention group (n=46) and the control group (n=45) in global quality of life (adjusted for baseline and type of surgery) after the first week was 10.1 (95% CI 1.8 to 18.5, P=.02). The intervention group summary scores were significantly higher than those of the control group after the first week (adjusted mean difference: 8.9, 95% CI 3.1 to 14.7, P=.003) and at the end of treatment (adjusted mean difference: 10.6, 95% CI 3.9 to 17.3, P=.002). Use of health resources was not statistically significant between the groups in either the first week (P=.12) or the first treatment cycle (P=.13). Exploratory analysis findings demonstrated clinically important improvements (indicated by EORTC C-30 or BR-23 scale scores)—social, physical, role, and cognitive function were improved while pain, appetite loss, and systemic therapy side effects were reduced. Conclusions: Use of the app enabled patients undergoing systemic therapy for early stage breast cancer to better cope with symptoms which was demonstrated by a better global quality of life and summary score after the first week and by a better summary score at the end of treatment in the intervention group compared to those of the control group, but no change in the use of health resources was demonstrated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593 · cited 1×
“Several studies [5-12] have shown the feasibility and clinical utility of electronic capture and monitoring of patient-reported outcome for symptoms, functional status, and quality of life during systemic treatment of cancer.”
BackgroundBasch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA · doi:10.1001/jama.2017.7156 · Cited by 2,302 · cited 1×
“Integration of the patient-reported outcome into routine care was even shown to prolong overall survival in patients with advanced solid tumors by 5 months [13].”
BackgroundDueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2639 · Cited by 1,030
Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y.-C., & Beer, T. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.025 · Cited by 555 · cited 1×
“Fromme et al [1] analyzed physician and patient reports on 8 symptoms in a metastatic prostate cancer chemotherapy trial and found that the physician reports had low sensitivity and specificity for detecting chemotherapy side effects [1].”
BackgroundResearch-Tested Mobile Apps for Breast Cancer Care: Systematic Review
Jongerius, C., Russo, S., Mazzocco, K., & Pravettoni, G. (2019) · JMIR mHealth and uHealth · doi:10.2196/10930 · Cited by 146
Zhu, J., Ebert, L., Liu, X., Wei, D., & Chan, S. W.-C. (2018) · JMIR mHealth and uHealth · doi:10.2196/mhealth.9438 · Cited by 124 · cited 4×
“Zhu et al [9] reported findings similar to ours, namely that the e-support group had better quality of life, self-efficacy, and symptom control than that of the group receiving standard care.”
BackgroundMethodResultInfluentialArmstrong, K. A., Semple, J. L., & Coyte, P. C. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3528 · Cited by 105
Kim, Y. H., Choi, K. S., Han, K., & Kim, H. W. (2018) · Journal of Clinical Nursing · doi:10.1111/jocn.13910 · Cited by 70
Foley, N. M., O'Connell, E. P., Lehane, E. A., Livingstone, V., Maher, B., Kaimkhani, S., Cil, T., Relihan, N., Bennett, M. W., Redmond, H. P., et al. (2016) · The Breast · doi:10.1016/j.breast.2016.08.012 · Cited by 68
Evidence on the Use of Mobile Apps During the Treatment of Breast Cancer: Systematic Review
Cruz, F. O. A. M., Vilela, R. A., Ferreira, E. B., Melo, N. S., & Reis, P. E. D. D. (2019) · JMIR mHealth and uHealth · doi:10.2196/13245 · Cited by 66 · cited 1×
“Recent mobile apps for women with breast cancer have a positive effect by promoting weight loss, decreasing stress, and improving the quality of life [35,36].”
Background
Cited by
Saevarsdottir, S. R., & Gudmundsdottir, S. L. (2023) · Journal of Medical Internet Research · doi:10.2196/42852 · Cited by 68
Akingbade, O., Nguyen, K. T., & Chow, K. M. (2023) · Journal of Clinical Nursing · doi:10.1111/jocn.16533 · Cited by 35
A systematic review of eHealth technologies for breast cancer supportive care
Gyawali, B., Bowman, M., Sharpe, I., Jalink, M., Srivastava, S., & Wijeratne, D. T. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102519 · Cited by 28
A systematic review of m-health apps on managing side effects of breast cancer treatment
Wanchai, A., Anderson, E. A., & Armer, J. M. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-022-07464-x · Cited by 17
Evaluating the Effectiveness of Mobile Health in Breast Cancer Care: A Systematic Review
Flaucher, M., Zakreuskaya, A., Nissen, M., Mocker, A., Fasching, P. A., Beckmann, M. W., Eskofier, B. M., & Leutheuser, H. (2023) · The Oncologist · doi:10.1093/oncolo/oyad217 · Cited by 15
“One of the studies 27 evaluated the self-reported number of doctor visits and hospitalizations of patients during therapy.”
BackgroundMethodInfluential
Metadata
- Authors
- Grašič Kuhar, C., Gortnar Cepeda, T., Kovač, T., Kukar, M., & Ružić Gorenjec, N.
- Venue
- JMIR mHealth and uHealth
- Publisher
- JMIR Publications Inc.
- Published
- 2020-08-04
- Volume
- 8
- Issue
- 8
- Pages
- e17408
- ISSN
- 2291-5222 (ISSN-L)
- OpenAlex
- W3024559336
- Cited by
- 42
- References
- 11
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study. https://app.cochat.ai/papers/10.2196/17408
- The paper
- Grašič Kuhar, C., Gortnar Cepeda, T., Kovač, T., Kukar, M., & Ružić Gorenjec, N. (2020). Mobile App for Symptom Management and Associated Quality of Life During Systemic Treatment in Early Stage Breast Cancer: Nonrandomized Controlled Prospective Cohort Study. JMIR mHealth and uHealth. https://doi.org/10.2196/17408
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.